会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明授权
    • Tetrahydro-benzthiazoles, the preparation thereof and their use as
intermediate products or as pharmaceuticals
    • 四氢 - 苯并噻唑,其制备方法及其作为中间产物或药物的用途
    • US4731374A
    • 1988-03-15
    • US810947
    • 1985-12-19
    • Gerhart Griss, deceasedRudolf HurnausWalter KobingerLudwig PichlerRudolf BauerJoachim MierauDieter HinzenGunter Schingnitz
    • Gerhart Griss, deceasedRudolf HurnausWalter KobingerLudwig PichlerRudolf BauerJoachim MierauDieter HinzenGunter Schingnitz
    • A61K31/425C07D277/82
    • C07D277/82
    • This invention relates to new tetrahydrobenzthiazoles of general formula ##STR1## wherein R.sub.1 represents a hydrogen atom, an alkyl group, an alkenyl or alkynylk group, an alkanoyl group, a phenyl alkyl or phenyl alkanoyl group, while the above mentioned phenyl nuclei may each be substituted by 1 or 2 halogen atoms,R.sub.2 represents a hydrogen atom or an alkyl group,R.sub.3 represents a hydrogen atom, an alkyl group a cycloalkyl group, an alkenyl or alkynyl group, an alkanoyl group, a phenyl alkyl or phenyl alkanoyl group, while the phenyl nucleus may be substituted by flurorine, chlorine or bromine atoms,R.sub.4 represents a hydrogen atom, an alkyl group, an alkyl or alkenyl group, orR.sub.3 and R.sub.4 together with the nitrogen atom between them represent a pyrrolidino, piperidino, hexamethyleneimino or morpholino group, the enantiomers and the acid addition salts thereof.The compounds of general formula I above in which one of the groups R.sub.1 or R.sub.3 or both groups R.sub.1 and R.sub.3 represent an acyl group are valuable intermediate products for preparing the other compounds of general formula I which have valuable pharmacological properties. The new compounds may be prepared using methods known per se.
    • 本发明涉及通式为(I)的新的四氢苯并噻唑,其中R 1表示氢原子,烷基,烯基或炔基,烷酰基,苯基烷基或苯基烷酰基,而上述苯基核 可各自被1或2个卤素原子取代,R2表示氢原子或烷基,R3表示氢原子,烷基,环烷基,烯基或炔基,烷酰基,苯基烷基或苯基烷酰基 基团可以被氟里酰,氯或溴原子取代,R4表示氢原子,烷基,烷基或烯基,或者R3和R4与它们之间的氮原子一起代表吡咯烷子基,哌啶子基, 六亚甲基亚氨基或吗啉代基,其对映异构体及其酸加成盐。 上述通式I的化合物,其中R1或R3基团或R1和R3两个基团之一表示酰基,是制备其它具有有价值的药理学性质的通式I化合物的有价值的中间产物。 新化合物可以使用本身已知的方法制备。